BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30321321)

  • 21. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice.
    Chang JJ; Chung DJ; Lee YJ; Wen BH; Jao HY; Wang CJ
    J Agric Food Chem; 2017 Oct; 65(42):9255-9265. PubMed ID: 28982243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
    Choi RY; Ham JR; Lee MK
    Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m
    Hu Y; Feng Y; Zhang L; Jia Y; Cai D; Qian SB; Du M; Zhao R
    RNA Biol; 2020 Jul; 17(7):930-942. PubMed ID: 32116145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
    PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
    Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
    Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
    Wu H; Jin M; Han D; Zhou M; Mei X; Guan Y; Liu C
    Biochem Biophys Res Commun; 2015 Mar; 458(4):862-8. PubMed ID: 25701781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.
    Wang CM; Yuan RS; Zhuang WY; Sun JH; Wu JY; Li H; Chen JG
    Lipids Health Dis; 2016 Nov; 15(1):195. PubMed ID: 27852305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.
    de Guia RM; Rose AJ; Sommerfeld A; Seibert O; Strzoda D; Zota A; Feuchter Y; Krones-Herzig A; Sijmonsma T; Kirilov M; Sticht C; Gretz N; Dallinga-Thie G; Diederichs S; Klöting N; Blüher M; Berriel Diaz M; Herzig S
    EMBO J; 2015 Feb; 34(3):344-60. PubMed ID: 25510864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
    Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
    [No Abstract]   [Full Text] [Related]  

  • 36. IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.
    Quiroga AD; Comanzo CG; Heit Barbini FJ; Lucci A; Vera MC; Lorenzetti F; Ferretti AC; Ceballos MP; Alvarez ML; Carrillo MC
    Toxicol Appl Pharmacol; 2019 Sep; 379():114650. PubMed ID: 31299271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet.
    Sales RC; Medeiros PC; Spreafico F; de Velasco PC; Gonçalves FKA; Martín-Hernández R; Mantilla-Escalante DC; Gil-Zamorano J; Peres WAF; de Souza SAL; Dávalos A; Tavares do Carmo MG
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
    Trasino SE; Tang XH; Jessurun J; Gudas LJ
    J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat Diets.
    Im AR; Kim YH; Kim YH; Yang WK; Kim SH; Song KH
    J Med Food; 2017 Dec; 20(12):1222-1232. PubMed ID: 29090980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.